Ansa Biotechnologies Breaks Traditional Synthetic DNA Length Barriers and Redefines Future of Life Science Research
安莎生物技术打破传统合成 DNA 长度障碍，重新定义生命科学研究的未来
- 关键词：
- 来源：
- Ansa Biotechnologies
- 类型：
- 前沿资讯
- 语种：
- 英语
- 原文发布日期：
- 2025-05-06
- 摘要：
- "Ansa Biotechnologies, Inc., the trusted partner for DNA synthesis, announced the launch of its 50 kb DNA synthesis early access program, providing customers with extremely long and complex DNA sequences in less than four weeks. DNA products of this length are essential for applications including synthetic genomics, metabolic engineering, agricultural research, and next-generation cell and gene therapies. Ansa will share more information about the early access program and showcase its ultra-rapid and highly accurate enzymatic DNA synthesis technology in booth #312 at the Global Synthetic Biology (SynBioBeta) Conference this week in San Jose, Calif. Ansa’s 50 kb DNA synthesis early access program builds on recent successes and sets a new industry benchmark for synthetic DNA delivery. Researchers can now order large constructs ranging from 7.5 kb to 50 kb. The program is designed to break traditional DNA length barriers, accelerate project timelines, and unlock transformative possibilities in many areas of life science research. “For decades, scientists have been handcuffed by short DNA fragments, forced to stitch sequences together in their own labs through tedious cloning techniques,” said Jason T. Gammack, CEO of Ansa Biotechnologies. “Ansa is now changing the game by delivering longer, more complex DNA, all with a transparent and collaborative service model. This rapid increase in our product length — from only 600 bases a year ago to 7.5 kb more recently and now 50 kb through early access — illustrates our tireless dedication to empowering researchers so they can build without limits and innovate without compromise.” Ansa’s synthesis services are powered by its proprietary enzymatic manufacturing process, which enables the direct synthesis of complex DNA sequences that are often difficult or even impossible to produce with legacy synthesis methods. The sequence-agnostic platform synthesizes DNA strands up to 750 bases long, which are then rapidly assembled into plasmids up to 50 kb. Once synthesized and assembled, constructs are verified using highly accurate long-read sequencing and a proprietary informatics pipeline to ensure that customers receive the exact DNA they ordered. Unlike traditional chemical synthesis, Ansa’s enzymatic approach uses no harsh chemicals, avoiding damage to the DNA molecule and enabling the synthesis of longer, more complex sequences. Entirely manufactured in the USA, Ansa’s DNA products are easy to integrate into any experimental workflow — and are ready to power the next wave of biological innovation. For more information about Ansa’s products, please visit"
- 所属专题：
- 177
